CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 87 filers reported holding CATALYST PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $3,375,000 | +49.7% | 730,557 | +26.7% | 0.32% | +19.6% |
| Q4 2017 | $2,255,000 | +112.9% | 576,825 | -36.3% | 0.26% | +15.2% |
| Q1 2016 | $1,059,000 | -70.3% | 905,000 | -37.8% | 0.23% | -55.9% |
| Q4 2015 | $3,565,000 | +8.0% | 1,455,000 | +32.3% | 0.52% | +24.0% |
| Q3 2015 | $3,300,000 | -33.4% | 1,100,000 | -8.3% | 0.42% | -13.2% |
| Q2 2015 | $4,956,000 | +4.1% | 1,200,000 | +9.1% | 0.48% | -2.2% |
| Q1 2015 | $4,763,000 | +51.3% | 1,100,000 | +3.8% | 0.50% | -7.5% |
| Q4 2014 | $3,148,000 | +38.3% | 1,060,000 | +54.6% | 0.54% | +90.7% |
| Q3 2014 | $2,276,000 | – | 685,500 | – | 0.28% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANAKA CAPITAL MANAGEMENT INC | 148,281 | $1,902,000 | 5.68% |
| GABLES CAPITAL MANAGEMENT INC. | 433,814 | $5,566,000 | 4.46% |
| Quantedge Capital Pte Ltd | 503,700 | $6,462,000 | 1.99% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,896,000 | $62,816,000 | 1.25% |
| Lanham O'Dell & Company, Inc. | 20,145 | $258,000 | 0.92% |
| Capital Impact Advisors, LLC | 59,301 | $907,000 | 0.90% |
| SummerHaven Investment Management, LLC | 98,840 | $1,268,000 | 0.88% |
| Yorktown Management & Research Co Inc | 50,000 | $642,000 | 0.83% |
| GLOBEFLEX CAPITAL L P | 304,293 | $3,904,000 | 0.67% |
| AFFINITY INVESTMENT ADVISORS, LLC | 90,864 | $1,166,000 | 0.60% |